Evaluation of the antibody response and adverse reactions of the BNT162b2 vaccine of participants with prior COVID-19 infection in Japan
View ORCID ProfileToshiya Mitsunaga, Yuhei Ohtaki, Yutaka Seki, Masakata Yoshioka, Hiroshi Mori, Midori Suzuka, Syunsuke Mashiko, Satoshi Takeda, Kunihiro Mashiko
doi: https://doi.org/10.1101/2021.07.18.21260579
Toshiya Mitsunaga
1Department of Emergency Medicine, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
2Department of Emergency Medicine, Jikei University School of Medicine, Tokyo, Japan
Yuhei Ohtaki
2Department of Emergency Medicine, Jikei University School of Medicine, Tokyo, Japan
Yutaka Seki
1Department of Emergency Medicine, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
3Department of Cardiology, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
4Department of Internal Medicine, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
Masakata Yoshioka
4Department of Internal Medicine, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
Hiroshi Mori
5Department of Medical Engineering, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
Midori Suzuka
6Department of Pharmacy, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
Syunsuke Mashiko
2Department of Emergency Medicine, Jikei University School of Medicine, Tokyo, Japan
Satoshi Takeda
2Department of Emergency Medicine, Jikei University School of Medicine, Tokyo, Japan
Kunihiro Mashiko
1Department of Emergency Medicine, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
Data Availability
We permit the use of the data available from the links below.
https://www.amazon.co.jp/clouddrive/share/RojSjHadBhY2LHhheayyqxRKphwwV51IP8tXscuA2E8
Posted July 22, 2021.
Evaluation of the antibody response and adverse reactions of the BNT162b2 vaccine of participants with prior COVID-19 infection in Japan
Toshiya Mitsunaga, Yuhei Ohtaki, Yutaka Seki, Masakata Yoshioka, Hiroshi Mori, Midori Suzuka, Syunsuke Mashiko, Satoshi Takeda, Kunihiro Mashiko
medRxiv 2021.07.18.21260579; doi: https://doi.org/10.1101/2021.07.18.21260579
Evaluation of the antibody response and adverse reactions of the BNT162b2 vaccine of participants with prior COVID-19 infection in Japan
Toshiya Mitsunaga, Yuhei Ohtaki, Yutaka Seki, Masakata Yoshioka, Hiroshi Mori, Midori Suzuka, Syunsuke Mashiko, Satoshi Takeda, Kunihiro Mashiko
medRxiv 2021.07.18.21260579; doi: https://doi.org/10.1101/2021.07.18.21260579
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2948)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12754)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4588)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4364)
- Nursing (236)
- Nutrition (640)
- Oncology (2273)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6947)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)